Zacks Investment Research
30 Oct 2025, 14:56 UTC · 46w ago
Wall Street Analysts Think Relay Therapeutics (RLAY) Could Surge 86.05%: Read This Before Placing a Bet
Verdict
Headline leans bullish. We score RLAY +0.80.
Score confirms the headline.
- Headline says
Leans bullish
From its wording — no explicit rating
- Expected · RLAY
+0.80strongly bullish





